Individual and Combined Effects of 2′-Fucosyllactose and Bifidobacterium longum subsp. infantis on the Gut Microbiota Composition of Piglets

被引:0
|
作者
Wang, Mei [1 ]
Monaco, Marcia H. [1 ]
Daniels, Victoria C. [2 ]
Hirvonen, Johanna [3 ]
Jensen, Henrik Max [4 ]
Ouwehand, Arthur C. [3 ]
Mukherjea, Ratna [5 ]
Christensen, Niels [4 ]
Lehtinen, Markus J. [3 ]
Hibberd, Ashley A. [6 ]
Dilger, Ryan N. [2 ,7 ]
Donovan, Sharon M. [1 ,2 ]
机构
[1] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA
[2] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA
[3] IFF Hlth & Biosci, Kantvik, Finland
[4] IFF R&D Enabling Technol, Adv Analyt, Brabrand, Denmark
[5] IFF Hlth & Biosci, St Louis, MO USA
[6] IFF Hlth & Biosci, Madison, WI USA
[7] Univ Illinois, Dept Anim Sci, Urbana, IL USA
来源
JOURNAL OF NUTRITION | 2025年 / 155卷 / 02期
关键词
gut microbiota; short-chain fatty acids; human milk oligosaccharides; 2'-fucosyllactose; Bifidobacterium longum subsp. infantis; HUMAN-MILK OLIGOSACCHARIDES; CHAIN FATTY-ACIDS; FECAL MICROBIOTA; FED FORMULA; BREAST; NUTRITION; MODEL; LIFE; MULTICENTER; CONSUMPTION;
D O I
10.1016/j.tjnut.2024.12.022
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Human milk is a source of oligosaccharides that promote the growth of beneficial bacteria, including Bifidobacterium longum subsp. infantis, which can utilize human milk oligosaccharides. Objectives: To evaluate the individual and combined effects of 2 '-fucosyllactose (2 '-FL), B. infantis Bi-26 (Bi-26) on piglet gut microbiota composition, and short-chain fatty acid (SCFA) concentrations. Methods: Intact male pigs (n = 63) had ad libitum access to milk replacer without (control; CON) or with 1.0 g/L 2 '-FL (FL) from postnatal day 2 to 34/35. Pigs were further stratified to receive either 12% glycerol or 10(9) CFU/d Bi-26 in glycerol (BI and FLBI). Gut microbiota and SCFA concentrations were determined in ascending colon contents (AC) and rectal contents (RC) by 16S ribosomal ribonucleic acid gene sequencing and gas chromatography, respectively. Microbiota composition and functional profiles were analyzed using QIIME 2 and Phylogenetic Investigation of Communities by Reconstruction of Unobserved States-2 (PICRUSt2). Results: Supplementation of 2 '-FL increased valerate concentration in AC (P = 0.03) and tended to modulate the overall bacterial composition in RC (P = 0.06). Compared with CON, 2 '-FL alone increased the acetate concentration in AC (P < 0.05). The addition of Bi-26 decreased Shannon indices and reduced propionate and butyrate concentrations in AC (P < 0.05). Bi-26 alone affected the relative abundances of several bacterial amplicon sequence variants (ASVs) in AC and RC, including the ASVs identified as Phocaeicola (Bacteroides) vulgatus and Faecalibacterium prausnitzii. Additionally, 2 '-FL and Bi-26 individually increased the relative abundances of 9 PICRUSt2-predicted metabolic pathways related to fatty acid and lipid biosynthesis or carboxylate degradation/secondary metabolite degradation in the RC; however, these effects were negated, and the values were identical to the CON group when 2 '-FL and Bi-26 were supplemented together. Conclusions: 2 '-FL and Bi-26 added to milk replacer exerted distinct influences on gut bacterial composition and metabolic function, and 2 '-FL alone increased specific SCFA concentrations, demonstrating its prebiotic potential.
引用
收藏
页码:509 / 522
页数:14
相关论文
共 50 条
  • [31] Interactions between the human milk oligosaccharide 2′-fucosyllactose and Bifidobacterium longum subspecies infantis in influencing systemic immune development and function in piglets
    Daniels, Victoria C.
    Monaco, Marcia H.
    Hirvonen, Johanna
    Ouwehand, Arthur C.
    Jensen, Henrik Max
    Mukerjea, Ratna
    Christensen, Niels
    Lehtinen, Markus J.
    Dilger, Ryan N.
    Donovan, Sharon M.
    FRONTIERS IN NUTRITION, 2024, 11
  • [32] Milk phospholipids protect Bifidobacterium longum subsp. infantis during in vitro digestion and enhance polysaccharide production
    Kosmerl, Erica
    Gonzalez-Orozco, Brianda D.
    Garcia-Cano, Israel
    Ortega-Anaya, Joana
    Jimenez-Flores, Rafael
    FRONTIERS IN NUTRITION, 2023, 10
  • [33] Bifidobacterium longum subsp. Infantis modulates intestinal immunity in growing mice in a strain-specific manner
    Zhang, Qing
    Ding, Mengfan
    Huang, Zheng
    Jiang, Shilong
    Zhao, Jianxin
    Stanton, Catherine
    Ross, R. Paul
    Chen, Wei
    Yang, Bo
    FOOD BIOSCIENCE, 2025, 68
  • [34] Draft Genome Sequence of Bifidobacterium longum subsp. infantis BI-G201, a Commercialization Strain
    Song, Jinan
    Xu, Yu
    Han, Di
    Teng, Qihui
    Jiang, Deyi
    Liu, Qing
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2020, 9 (47):
  • [35] Genome-scale metabolic modeling of the human milk oligosaccharide utilization by Bifidobacterium longum subsp. infantis
    Roman, Loreto
    Melis-Arcos, Felipe
    Proschle, Tomas
    Saa, Pedro A.
    Garrido, Daniel
    MSYSTEMS, 2024, 9 (03)
  • [36] Beneficial effects of Bifidobacterium longum subsp. longum BB536 on human health: Modulation of gut microbiome as the principal action
    Wong, Chyn Boon
    Odamaki, Toshitaka
    Xiao, Jin-zhong
    JOURNAL OF FUNCTIONAL FOODS, 2019, 54 : 506 - 519
  • [37] Effect of Bifidobacterium animalis subsp. lactis MN-Gup on constipation and the composition of gut microbiota
    Wang, R.
    Sun, J.
    Li, G.
    Zhang, M.
    Niu, T.
    Kang, X.
    Zhao, H.
    Chen, J.
    Sun, E.
    Li, Y.
    BENEFICIAL MICROBES, 2021, 12 (01) : 31 - 42
  • [38] Bifidobacterium longum subsp infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota
    Underwood, Mark A.
    Arriola, Jennifer
    Gerber, Colin W.
    Kaveti, Ashwini
    Kalanetra, Karen M.
    Kananurak, Anchasa
    Bevins, Charles L.
    Mills, David A.
    Dvorak, Bohuslav
    PEDIATRIC RESEARCH, 2014, 76 (04) : 326 - 333
  • [39] tuf Gene Sequence Variation in Bifidobacterium longum subsp infantis Detected in the Fecal Microbiota of Chinese Infants
    Lawley, Blair
    Centanni, Manuela
    Watanabe, Jun
    Sims, Ian
    Carnachan, Susan
    Broadbent, Roland
    Lee, Pheng Soon
    Wong, Khai Hong
    Tannock, Gerald W.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2018, 84 (13)
  • [40] Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial
    Vladimir Ivashkin
    Victor Fomin
    Sergey Moiseev
    Michail Brovko
    Roman Maslennikov
    Anatoly Ulyanin
    Victoria Sholomova
    Maria Vasilyeva
    Elizaveta Trush
    Oleg Shifrin
    Elena Poluektova
    Probiotics and Antimicrobial Proteins, 2023, 15 : 460 - 468